Plain-English translation of NCT06082804 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a specially trained advanced practice nurse can improve care for people with chronic myeloid leukemia who are taking oral medications. The study compares two groups: one group will see both a nurse and their regular doctor, while the other group will see only their doctor (the standard approach). The main goal is to see if the nurse can help catch and manage side effects early, which might improve how well the medication works and how patients feel.
Many patients taking this medication experience mild to moderate side effects that they don't always report to their doctors, which can affect how well the treatment works and whether they stay on it. This trial exists to see if a specially trained nurse can catch these side effects earlier and help manage them better, ultimately improving patient outcomes and quality of life.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either the nurse-plus-doctor group or the doctor-only group. The nurse group will have regular appointments with both a specialized nurse and their hematologist, where the nurse will watch for side effects, help manage them, and answer questions about taking the medication. You will complete questionnaires about your quality of life and how you're doing on the treatment. The study will track how well your treatment is working and how you feel over time.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
France